[go: up one dir, main page]

FI830879A0 - Foerfarande foer framstaellning av triazolderivat anvaendbara saosom saorbildning motverkande laeke - Google Patents

Foerfarande foer framstaellning av triazolderivat anvaendbara saosom saorbildning motverkande laeke

Info

Publication number
FI830879A0
FI830879A0 FI830879A FI830879A FI830879A0 FI 830879 A0 FI830879 A0 FI 830879A0 FI 830879 A FI830879 A FI 830879A FI 830879 A FI830879 A FI 830879A FI 830879 A0 FI830879 A0 FI 830879A0
Authority
FI
Finland
Prior art keywords
sub
sup
alkyl
triazolderivat
saorbildning
Prior art date
Application number
FI830879A
Other languages
English (en)
Other versions
FI830879L (fi
FI830879A7 (fi
Inventor
Richard Paul Pioch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI830879A0 publication Critical patent/FI830879A0/fi
Publication of FI830879L publication Critical patent/FI830879L/fi
Publication of FI830879A7 publication Critical patent/FI830879A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194—Radicals derived from thio- or thiono carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Earth Drilling (AREA)
  • Inert Electrodes (AREA)
  • Treating Waste Gases (AREA)
  • Fats And Perfumes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
FI830879A 1982-03-19 1983-03-16 Menetelmä haavauman vastaisina lääkeaineina käyttökelpoisten tiatsolijohdannaisten valmistamiseksi. FI830879A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/360,034 US4474794A (en) 1982-03-19 1982-03-19 N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds

Publications (3)

Publication Number Publication Date
FI830879A0 true FI830879A0 (fi) 1983-03-16
FI830879L FI830879L (fi) 1983-09-20
FI830879A7 FI830879A7 (fi) 1983-09-20

Family

ID=23416322

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830879A FI830879A7 (fi) 1982-03-19 1983-03-16 Menetelmä haavauman vastaisina lääkeaineina käyttökelpoisten tiatsolijohdannaisten valmistamiseksi.

Country Status (22)

Country Link
US (1) US4474794A (fi)
EP (1) EP0091220B1 (fi)
JP (1) JPS58170773A (fi)
KR (1) KR840004091A (fi)
AT (1) ATE27156T1 (fi)
AU (1) AU1254583A (fi)
CA (1) CA1190547A (fi)
CS (1) CS236788B2 (fi)
DD (1) DD207376A5 (fi)
DE (1) DE3371514D1 (fi)
DK (1) DK91083A (fi)
ES (1) ES8405386A1 (fi)
FI (1) FI830879A7 (fi)
GB (1) GB2116973B (fi)
GR (1) GR77882B (fi)
IL (1) IL68152A0 (fi)
NZ (1) NZ203605A (fi)
PH (1) PH18504A (fi)
PL (1) PL241066A1 (fi)
PT (1) PT76397B (fi)
RO (1) RO85385B (fi)
ZA (1) ZA831882B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
EP0285681B1 (de) * 1987-04-06 1993-03-10 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von Nitroethenderivaten
NL9000132A (nl) * 1990-01-19 1991-08-16 Cedona Pharm Bv Nieuwe thiazoolderivaten.
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
EP0091220B1 (en) 1987-05-13
EP0091220A3 (en) 1984-05-23
ATE27156T1 (de) 1987-05-15
DD207376A5 (de) 1984-02-29
GR77882B (fi) 1984-09-25
PH18504A (en) 1985-08-02
NZ203605A (en) 1985-10-11
CS236788B2 (en) 1985-05-15
JPS58170773A (ja) 1983-10-07
PT76397B (en) 1986-02-04
US4474794A (en) 1984-10-02
ES520791A0 (es) 1984-06-01
RO85385B (ro) 1984-11-30
ES8405386A1 (es) 1984-06-01
FI830879L (fi) 1983-09-20
EP0091220A2 (en) 1983-10-12
PL241066A1 (en) 1985-01-02
FI830879A7 (fi) 1983-09-20
KR840004091A (ko) 1984-10-06
GB8307201D0 (en) 1983-04-20
RO85385A (ro) 1984-11-25
ZA831882B (en) 1984-11-28
IL68152A0 (en) 1983-06-15
GB2116973A (en) 1983-10-05
GB2116973B (en) 1985-08-29
AU1254583A (en) 1983-09-22
DK91083D0 (da) 1983-02-25
PT76397A (en) 1983-04-01
CA1190547A (en) 1985-07-16
DE3371514D1 (en) 1987-06-19
DK91083A (da) 1983-09-20

Similar Documents

Publication Publication Date Title
KR830007624A (ko) 헤테로 사이클릭 화합물의 제조방법
ATE94065T1 (de) Diazepine enthaltende pharmazeutische zusammensetzungen mit plaettchen aktivierender faktor (paf)-antagonistischer wirkung.
DK247479A (da) 1-phenyl-2-aminoethanolderivater
KR940005633A (ko) 약제학적으로 유용한 항경련제 설파메이트의 이미데이트 유도체
ES8707948A1 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES383868A1 (es) Un procedimiento de preparar oxindolcarboxamidas.
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
EP0125803A3 (en) Pharmaceutically active dihydropyridines
FI830879A0 (fi) Foerfarande foer framstaellning av triazolderivat anvaendbara saosom saorbildning motverkande laeke
KR900018042A (ko) 부텐산 유도체
JPS6438091A (en) Condensed heterocyclic sulfonylurea
IL71503A0 (en) Disubstituted polymethylene imines,their preparation and pharmaceutical compositions containing them
ES479110A1 (es) Procedimiento para preparar derivados de benzamidina.
ATE5586T1 (de) Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
GB1031165A (en) Guanidines, isoureas and isothioureas
ATE15796T1 (de) Benzhydrylsulfinylethylamine, verfahren zu deren herstellung und verwendung in der therapeutik.
EP0372410A3 (en) Use of heterocyclic amides to inhibit tumor metastasis
DK60793D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.
ES8607726A1 (es) Procedimiento para preparar pirido(i,4)benzodiazepinas
TH630A (th) N-(อาริลไธโออัลคิล)-n'-(อมิโนอัลคิล)ยูเรีย
TH3061A (th) 2-(อัลคอกซิมิโนอัลคอกซีคาร์บอนิล)-เฟนนิลซัลโฟนิลซัลโฟนิลยูเรีย
IT1127215B (it) Nuove 2-fenilammino-imidazoline-(2)sostitutite,dotate di particolari proprieta' terapeutiche,loro processo di sintesi e composizioni farmaceutiche
RU97107473A (ru) Бициклические производные амидина, которые можно использовать в терапии
BG46157A3 (bg) Метод за получаване на n-алкил(ен)-n-(о,о-дву- заместен тиофосфорил- n', n' - двузаместени глицинамиди

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: ELI LILLY AND COMPANY